Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1

por Tayshetye, Pritam, Friday, Andrew J., Omstead, Ashten N., Verma, Tanvi, Miller, Stacey, Zheng, Ping, Jani, Prashant, Zaidi, Ali, Finley, Gene
Publicado 2022

Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence

por Ayazi, Shahin, Chowdhury, Nobel, Zaidi, Ali H., Chovanec, Kristy, Komatsu, Yoshihiro, Omstead, Ashten N., Zheng, Ping, Hoppo, Toshitaka, Jobe, Blair A.
Publicado 2019

Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management

por Ayazi, Shahin, Zheng, Ping, Zaidi, Ali H., Chovanec, Kristy, Chowdhury, Nobel, Salvitti, Madison, Komatsu, Yoshihiro, Omstead, Ashten N., Hoppo, Toshitaka, Jobe, Blair A.
Publicado 2019

High yield reproducible rat model recapitulating human Barrett’s carcinogenesis

por Matsui, Daisuke, Omstead, Ashten N, Kosovec, Juliann E, Komatsu, Yoshihiro, Lloyd, Emily J, Raphael, Hailey, Kelly, Ronan J, Zaidi, Ali H, Jobe, Blair A
Publicado 2017

Measurement of outflow resistance imposed by magnetic sphincter augmentation: defining normal values and clinical implication

por Ayazi, Shahin, Grubic, Andrew D., Zheng, Ping, Zaidi, Ali H., Schwameis, Katrin, Alleyne, Adam C., Myers, Brittney M., Omstead, Ashten N., Jobe, Blair A.
Publicado 2020

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

por Matani, Hirsch, Sahu, Divya, Paskewicz, Michael, Gorbunova, Anastasia, Omstead, Ashten N., Wegner, Rodney, Finley, Gene G., Jobe, Blair A., Kelly, Ronan J., Zaidi, Ali H., Goel, Ajay
Publicado 2022

CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease

por Kosovec, Juliann E., Zaidi, Ali H., Omstead, Ashten N., Matsui, Daisuke, Biedka, Mark J., Cox, Erin J., Campbell, Patrick T., Biederman, Robert W.W., Kelly, Ronan J., Jobe, Blair A.
Publicado 2017

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma

por Babar, Laila, Kosovec, Juliann E., Jahangiri, Vida, Chowdhury, Nobel, Zheng, Ping, Omstead, Ashten N., Salvitti, Madison S., Smith, Matthew A., Goel, Ajay, Kelly, Ronan J., Jobe, Blair A., Zaidi, Ali H.
Publicado 2019

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model

por Zaidi, Ali H., Kelly, Ronan J., Gorbunova, Anastasia, Omstead, Ashten N., Salvitti, Madison S., Zheng, Ping, Kosovec, Juliann E., Lee, Soyoung, Ayazi, Shahin, Babar, Laila, Finley, Gene G., Goel, Ajay, Jobe, Blair A.
Publicado 2021

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma

por Matsui, Daisuke, Zaidi, Ali H., Martin, Samantha A., Omstead, Ashten N., Kosovec, Juliann E., Huleihel, Luai, Saldin, Lindsey T., DiCarlo, Christina, Silverman, Jan F., Hoppo, Toshitaka, Finley, Gene G., Badylak, Stephen F., Kelly, Ronan J., Jobe, Blair A.
Publicado 2016

Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma

por Zaidi, Ali H., Kelly, Lori A., Kreft, Rachael E., Barlek, Mark, Omstead, Ashten N., Matsui, Daisuke, Boyd, Natalie H., Gazarik, Kathryn E., Heit, Megan I., Nistico, Laura, Kasi, Pashtoon M., Spirk, Tracy L., Byers, Barbara, Lloyd, Emily J., Landreneau, Rodney J., Jobe, Blair A.
Publicado 2016